Aemetis (NASDAQ:AMTX) Shares Pass Below 200 Day Moving Average of $4.34

Aemetis, Inc. (NASDAQ:AMTX) shares crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $4.34 and traded as low as $4.31. Aemetis shares last traded at $4.47, with a volume of 618,498 shares.

Analyst Ratings Changes

AMTX has been the subject of a number of recent research reports. Stifel Nicolaus dropped their price target on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating for the company in a research note on Wednesday, February 21st. Truist Financial lowered their target price on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating for the company in a research note on Tuesday, January 23rd.

Aemetis Price Performance

The stock has a market cap of $190.46 million, a P/E ratio of -3.39 and a beta of 1.01. The company’s 50 day simple moving average is $4.05 and its 200 day simple moving average is $4.34.

Aemetis (NASDAQ:AMTX) last issued its earnings results on Thursday, March 7th. The specialty chemicals company reported ($0.34) EPS for the quarter, beating the consensus estimate of ($0.35) by $0.01. The firm had revenue of $70.76 million during the quarter, compared to the consensus estimate of $80.08 million. During the same period in the previous year, the company posted ($0.63) EPS. On average, equities research analysts predict that Aemetis, Inc. will post -1.44 earnings per share for the current year.

Institutional Investors Weigh In On Aemetis

Several large investors have recently made changes to their positions in AMTX. Point72 Asset Management L.P. bought a new stake in shares of Aemetis during the second quarter worth $25,000. Barclays PLC increased its position in shares of Aemetis by 542.0% during the fourth quarter. Barclays PLC now owns 8,031 shares of the specialty chemicals company’s stock worth $32,000 after acquiring an additional 6,780 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Aemetis by 173.7% during the third quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 3,545 shares in the last quarter. Deutsche Bank AG increased its position in shares of Aemetis by 66.9% during the first quarter. Deutsche Bank AG now owns 18,454 shares of the specialty chemicals company’s stock worth $43,000 after acquiring an additional 7,395 shares in the last quarter. Finally, BNP Paribas Arbitrage SA increased its position in shares of Aemetis by 105.6% during the second quarter. BNP Paribas Arbitrage SA now owns 9,517 shares of the specialty chemicals company’s stock worth $47,000 after acquiring an additional 4,887 shares in the last quarter. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.